Paris - the founder and majority shareholder of Bio-Access, Jean-Louis Oger, announced announce that he's signed today, alongside its shareholders and executives, an agreement with Eurofins Scientific the leading global provider in the market for bio-analysis and one of the world leader in genomic services for the control Group assignment. Several current shareholders of Bio-Access, biologists and managers co-invest alongside Eurofins and Jean-Louis Oger.

The Mayer Brown team included:

  • Jean-François Louit, partner
  • Alexandre Dejardin, partner
  • Caroline Lan, associate
  • Jérémy Thézée, associate
  • Barbara Petrovic, associate.